Cargando…
S1P(1) deletion differentially affects TH17 and Regulatory T cells
Sphingosine-1 phosphate receptor 1 (S1P(1)) is critical for the egress of T and B cells out of lymphoid organs. Although S1P(1) agonist fingolimod is currently used for the treatment of multiple sclerosis (MS) little is known how S1P(1) signaling regulates Th17 and T(reg) cell homeostasis. To study...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5635040/ https://www.ncbi.nlm.nih.gov/pubmed/29018225 http://dx.doi.org/10.1038/s41598-017-13376-2 |